An Alternative Booster Vaccine Against Meningitis and Ear Infections.
Phase of Trial: Phase III
Latest Information Update: 20 Mar 2018
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 10 Jan 2018 Results of comparison of immunisation site pain between 10- or 13-Valent Pneumococcal Conjugate Vaccine published in the Pediatric Infectious Disease Journal.
- 06 Nov 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 07 Aug 2015 Planned End Date changed from 1 Jun 2014 to 1 Sep 2015 as reported by ClinicalTrials.gov record